Menu Menu


GLAXF Financials       Clear


GLAXF        0001131399    
Filing Date Form Type Description Document
2020-02-14 SC 13G SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP View Document
2020-02-14 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-02-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-02-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-02-11 6-K TRANSFER OF TREASURY SHARES View Document
2020-02-06 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-02-05 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-02-05 6-K FINAL RESULTS View Document
2020-02-05 SC 13G/A View Document
2020-02-03 6-K/A GSK PUBLISHES PROVISIONAL 2020 DIVIDEND DATES View Document
2020-02-03 6-K TOTAL VOTING RIGHTS View Document
2020-01-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-01-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-01-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-01-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-01-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-01-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-01-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-01-08 6-K GSK ANNOUNCES ADDITION TO CORPORATE EXECUTIVE TEAM View Document
2020-01-08 6-K GSK PUBLISHES PROVISIONAL 2020 DIVIDEND DATES View Document
2020-01-02 3 OWNERSHIP DOCUMENT View Document
2020-01-02 6-K TOTAL VOTING RIGHTS View Document
2019-12-23 6-K VIIV HEALTHCARE RECEIVES COMPLETE RESPONSE LETTER View Document
2019-12-20 S-8 FORM S-8 View Document
2019-12-18 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-12-18 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-12-17 6-K BLOCKLISTING APPLICATION View Document
2019-12-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-12-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-12-05 6-K VIIV SUBMITS NDA TO FDA FOR FOSTEMSAVIR View Document
2019-12-04 6-K EMMA WALMSLEY - EXTERNAL APPOINTMENT View Document
2019-12-02 6-K TOTAL VOTING RIGHTS View Document
2019-12-02 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-11-26 6-K BLOCK LISTING INTERIM REVIEW View Document
2019-11-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-11-08 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-11-06 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-11-04 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-11-01 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-11-01 6-K TOTAL VOTING RIGHTS View Document
2019-10-31 4 OWNERSHIP DOCUMENT View Document
2019-10-31 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-10-30 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-10-30 6-K 3RD QUARTER RESULTS View Document
2019-10-24 3 OWNERSHIP DOCUMENT View Document
2019-10-22 4 OWNERSHIP DOCUMENT View Document
2019-10-21 6-K GSK DIVESTS TWO TRAVEL VACCINES TO BAVARIAN NORDIC View Document
2019-10-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-10-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-10-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-10-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-10-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-10-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-10-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-10-01 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-10-01 6-K TOTAL VOTING RIGHTS View Document
2019-09-30 6-K DATA SHOW ANTI-TUMOUR ACTIVITY WITH ICOS AGONIST View Document
2019-09-30 6-K PRIMA SHOWS ZEJULA IMPROVES PFS IN OVARIAN CANCER View Document
2019-09-26 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-09-17 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-09-12 4 OWNERSHIP DOCUMENT View Document
2019-09-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-09-04 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-09-04 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-09-04 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-09-03 6-K TOTAL VOTING RIGHTS View Document
2019-08-23 6-K GSK - POSITIVE RESULTS FROM PIVOTAL DREAMM-2 STUDY View Document
2019-08-22 6-K VIIV RESULTS POSITIVE FOR EVERY 2 MONTH INJECTION View Document
2019-08-21 6-K GSK SUBMITS REGULATORY FILE IN JAPAN: DAPRODUSTAT View Document
2019-08-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-08-01 6-K EU APPROVAL FOR NUCALA SELF-ADMINISTRATION View Document
2019-08-01 6-K TOTAL VOTING RIGHTS View Document
2019-08-01 6-K GSK COMPLETES TRANSACTION WITH PFIZER FOR NEW JV View Document
2019-07-30 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-07-29 EFFECT View Document
2019-07-29 6-K VIIV SUBMITS CABOTEGRAVIR TO EMA FOR HIV INJECTION View Document
2019-07-25 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2019-07-24 6-K 2ND QUARTER RESULTS View Document
2019-07-24 4 FORM 4 View Document
2019-07-24 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-07-24 6-K VIIV 2DR TANGO SWITCH STUDY POSITIVE AT 48 WEEKS View Document
2019-07-24 6-K VIIV GEMINI STUDIES SHOW HIGH EFFICACY AT 96 WEEKS View Document
2019-07-24 6-K NON-EXECUTIVE CHAIRMAN View Document
2019-07-22 6-K VIIV PRESENTS 96-WEEK DATA FROM PHASE III STUDY View Document
2019-07-19 F-6 View Document
2019-07-17 3 OWNERSHIP DOCUMENT View Document
2019-07-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-07-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-07-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-07-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-07-15 6-K POSITIVE RESULTS IN PHASE 3 PRIMA STUDY OF ZEJULA View Document
2019-07-12 SC 13D View Document
2019-07-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-07-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-07-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2019-07-10 6-K VIIV SWITCH STUDY SHOWS 2DR AS EFFECTIVE AS 3DR View Document
2019-07-03 6-K VIIV RECEIVES DOVATO EU MARKETING AUTHORISATION View Document
2019-07-02 11-K View Document
2019-07-02 11-K View Document
2019-07-02 4 OWNERSHIP DOCUMENT View Document

Find registration statements, periodic reports, and other forms by typing ticker symbol of a company.

Ticker:

Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.



We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas